
1:00
T cells fight infection by killing invaders and coordinating immune response, but in cancer and autoimmune disease they stay stuck in overdrive. Low-dose naltrexone can help dial them back down when normal regulation fails.

T cells fight infection by killing invaders and coordinating immune response, but in cancer and autoimmune disease they stay stuck in overdrive. Low-dose naltrexone can help dial them back down when normal regulation fails.
So T, like Thomas, T cells. You've heard of B cells, that's the antibody immunity. T cells are part of cell-mediated immunity, and they have subcategories. The famous ones are the cytotoxic or the killer T cells. Those are directly killing something. But then there are T helper families, bunch of different families there, T regulatory families, and they all kind of work together. Now, if that family of T cells is doing everything it's supposed to, it'll upregulate sometimes when we're, say, sick, and downregulate and modulate the rest of the time. If we If we have cancer, if we have autoimmunity, if we have some other chronic inflammatory problem, or even certain types of pain syndromes going on, the T-cell family is not autoregulating very well. And so one of the many ways that we can introduce help there is by bringing a regulator in. And so if we give high-dose naltrexone, it doesn't work. But if we drop the dose down and give low-dose naltrexone, we can modulate the T-cell families